Atea Pharmaceuticals Inc. (AVIR)

2.92

-0.11 (-3.63%)

At close: Mar 03, 2025, 3:59 PM

2.90

-0.68%

After-hours: Mar 03, 2025, 07:14 PM EST

Atea Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-135.96M	-115.91M	121.19M	-10.95M	-14.03M	-9.06M
Depreciation & Amortization	416K	260K	29K	19K	17K	17K
Stock-Based Compensation	49.43M	46.72M	39.62M	7.46M	624K	414K
Other Working Capital	14.46M	-44.6M	-258.13M	301.37M	422K	815K
Other Non-Cash Items	33.11M	-5.46M	29.39M	13.8M	501K	538K
Deferred Income Tax	-48.56M	n/a	-29.39M	-13.8M	-501K	n/a
Change in Working Capital	16.16M	-46.59M	-247.84M	300.2M	579K	725K
Operating Cash Flow	-85.39M	-120.98M	-87M	296.73M	-12.81M	-7.91M
Capital Expenditures	n/a	-1.94M	-4K	-26K	-2K	-12K
Acquisitions	n/a	453.47K	n/a	n/a	n/a	n/a
Purchase of Investments	-562.36M	-545.35M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	602.66M	91.89M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-453.47K	n/a	n/a	n/a	n/a
Investing Cash Flow	40.3M	-455.41M	-4K	-26K	-2K	-12K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	257K	140K	n/a	214.12M	n/a	54.84M
Financial Cash Flow	257K	370K	1.47M	531.75M	-15K	27.48M
Net Cash Flow	-44.84M	-576.02M	-85.54M	828.46M	-12.83M	19.56M
Free Cash Flow	-85.39M	-122.92M	-87.01M	296.71M	-12.82M	-7.92M